Biogen And Neomorph Collaborate To Develop Molecular Glue Degraders For Alzheimer's And More
30/10 03:42
(RTTNews) - Biogen Inc. (BIIB) and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders for priority targets in Alzheimer's, rare neurological, and immunological diseases....
